Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
74
-
Total shares
-
38.8M
-
Shares change
-
+3.56M
-
Total reported value, excl. options
-
$47M
-
Value change
-
+$4.28M
-
Put/Call ratio
-
0.7
-
Number of buys
-
27
-
Number of sells
-
-30
-
Price
-
$1.21
Significant Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q1 2017
78 filings reported holding TRXC - TRANSENTERIX INC - COM NEW as of Q1 2017.
TRANSENTERIX INC - COM NEW (TRXC) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.8M shares
.
Largest 10 shareholders include Aisling Capital LLC (8.34M shares), SV Health Investors, LLC (7.55M shares), JPMORGAN CHASE & CO (4.23M shares), BlackRock Inc. (3.72M shares), StepStone Group LP (3.03M shares), VANGUARD GROUP INC (2.42M shares), MASTERS CAPITAL MANAGEMENT LLC (1.9M shares), STATE STREET CORP (1.03M shares), INTERNATIONAL BIOTECHNOLOGY TRUST PLC (889K shares), and NORTHERN TRUST CORP (693K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.